
# Title 21— FOOD AND DRUGS
### CHAPTER 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT
#### § 360bbb–4b. Medical countermeasure master files
##### (f) Definitions

In this section:

(1) The term “master file holder” means a person who submits data and information to the Secretary with the intent to reference or authorize another person to reference such data or information to support a medical countermeasure submission, as described in subsection (a).

(2) The term “medical countermeasure submission” means an investigational new drug application under section 355(i) of this title , a new drug application under section 355(b) of this title , or an abbreviated new drug application under section 355(j) of this title , a biological product license application under section 351(a) of the Public Health Service Act [ 42 U.S.C. 262(a) ] or a biosimilar biological product license application under section 351(k) of the Public Health Service Act [ 42 U.S.C. 262(k) ], a new animal drug application under section 360b(b)(1) of this title or abbreviated new animal drug application under section 360b(b)(2) of this title , an application for conditional approval of a new animal drug under section 360ccc of this title , an investigational device application under section 360j(g) of this title , an application with respect to a device under section 360e(c) of this title , a request for classification of a device under section 360c(f)(2) of this title , a notification with respect to a device under section 360(k) of this title , or a request for an emergency use authorization under section 360bbb–3 of this title to support

(A) the approval, licensure, classification, clearance, conditional approval, or authorization of a security countermeasure, qualified countermeasure, or qualified pandemic or epidemic product; or

(B) a new indication to an approved security countermeasure, qualified countermeasure, or qualified pandemic or epidemic product.

(3) The terms “qualified countermeasure”, “security countermeasure”, and “qualified pandemic or epidemic product” have the meanings given such terms in sections 319F–1, 319F–2, and 319F–3, respectively, of the Public Health Service Act [ 42 U.S.C. 247d–6a , 247d–6b, 247d–6d].
